Back to Search
Start Over
In Vivo Neutralization of Myotoxin II, a Phospholipase A 2 Homologue from Bothrops asper Venom, Using Peptides Discovered via Phage Display Technology.
- Source :
-
ACS omega [ACS Omega] 2022 Apr 25; Vol. 7 (18), pp. 15561-15569. Date of Electronic Publication: 2022 Apr 25 (Print Publication: 2022). - Publication Year :
- 2022
-
Abstract
- Many snake venom toxins cause local tissue damage in prey and victims, which constitutes an important pathology that is challenging to treat with existing antivenoms. One of the notorious toxins that causes such effects is myotoxin II present in the venom of the Central and Northern South American viper, Bothrops asper . This Lys49 PLA <subscript>2</subscript> homologue is devoid of enzymatic activity and causes myotoxicity by disrupting the cell membranes of muscle tissue. To improve envenoming therapy, novel approaches are needed, warranting the discovery and development of inhibitors that target key toxins that are currently difficult to neutralize. Here, we report the identification of a new peptide (JB006), discovered using phage display technology, that is capable of binding to and neutralizing the toxic effects of myotoxin II in vitro and in vivo . Through computational modeling, we further identify hypothetical binding interactions between the toxin and the peptide to enable further development of inhibitors that can neutralize myotoxin II.<br />Competing Interests: The authors declare the following competing financial interest(s): B.Lohse is a founder of the company Serpentides ApS, which holds a patent (PCT/EP2019/057522) covering the use of the peptides described in this article.<br /> (© 2022 The Authors. Published by American Chemical Society.)
Details
- Language :
- English
- ISSN :
- 2470-1343
- Volume :
- 7
- Issue :
- 18
- Database :
- MEDLINE
- Journal :
- ACS omega
- Publication Type :
- Academic Journal
- Accession number :
- 35571794
- Full Text :
- https://doi.org/10.1021/acsomega.2c00280